Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up
1998

Do Urinary Oestrogen Metabolites Predict Breast Cancer?

Sample size: 5104 publication Evidence: moderate

Author Information

Author(s): EN Meilahn, B De Stavola, DS Allen, I Fentiman, HL Bradlow, DW Sepkovic, LH Kuller

Primary Institution: London School of Hygiene and Tropical Medicine

Hypothesis

Does metabolism favoring the more oestrogenic 16a-OHE1 pathway increase breast cancer risk?

Conclusion

The study suggests that a higher ratio of 2:16a-OHE1 may be linked to a lower risk of breast cancer, although the results were not statistically significant.

Supporting Evidence

  • Post-menopausal women who developed breast cancer had a 15% lower 2:16a-OHE1 ratio than matched controls.
  • Subjects with metabolite ratios in the highest tertile of 2:16a-OHE1 had about a 30% lower risk than those in the lowest two-thirds.
  • The study included a total of 102 incident breast cancer cases and 296 matched control subjects.

Takeaway

This study looked at how certain substances in urine might help predict breast cancer risk in women, showing that some women might be at lower risk based on their urine test results.

Methodology

The study measured urinary oestrogen metabolites in women aged 35 and older from Guernsey, comparing those who developed breast cancer with matched controls.

Limitations

The study lacked sufficient power to detect statistically significant differences due to a small number of cases.

Participant Demographics

Women aged 35 and older from Guernsey, with both premenopausal and postmenopausal participants.

Statistical Information

Confidence Interval

95% CI = 0.29-1.75

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication